Categories AlphaGraphs, Earnings, Technology

Adobe Systems beats estimates in Q1

Shares of Adobe Systems (ADBE) fell 0.8% during extended trading Thursday, despite the software solutions provider reporting stronger-than-expected earnings for the first quarter, helped by a marked increase in revenues.

Revenues of the San Jose, California-based firm climbed 25% to $2.60 billion in the first quarter, beating analysts’ estimate of $2.54 billion.

Adjusted earnings jumped 10% year-on-year to $1.71 per share, surpassing the market consensus of $1.61 per share. On a reported basis, Q1 profit was $1.36 per share, compared to $1.17 per share recorded in the first quarter of 2017.

CEO Shantanu Narayen said, “Adobe is fueling the creative economy, driving the paper-to-digital revolution and enabling businesses to transform through our leadership in customer experience management.”

READ: BLACKBERRY SETS UP NEW GOVERNMENT SOLUTIONS UNIT

For fiscal 2019, the digital publishing and analytics firm expects adjusted earnings of about $7.80 per share on revenues of approximately $11.150 billion. For the second quarter, the company expects adjusted earnings of $1.77 per share on revenue of about $2.7 billion.

Adobe shares have gained 22% in the trailing 52 weeks, compared to 2% recorded by the S&P 500 index. During the year-to-date period, ADBE shares have increased by 18%.

READ: PINDUODUO STOCK PLUNGES ON WEAK Q4 EARNINGS

Adobe has an average 12-month price target of $267, which is at a 0.7% upside from the last close.

 

Earnings Calendar: Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top